Increased Share Price
The Third Technology
Looking Forward Statement
Oil Exploration

Just click on one of these websites and enter symbol: NYVA

www.pinksheets.com  
www.bloomberg.com 
www.cnbc.com  
www.ragingbull.com

These websites also provide: Price History Charts, Daily & Monthly Trading Volume, Bid-Asked, etc.

Benchmarking Nyvatex’s 
Common Stock Share Price (Biotech)

(What is the possibility of increasing share price?)

Throughout investment history, the most widely used method to estimate the potential worth of presently assumed unrecognized investment or speculative values of an exclusive science, invention or idea is to measure it against a “benchmark” of an established inferior, superior or similar technology.

Wall Street stock professionals refer to this comparative evaluation as “benchmarking”, which word is borrowed from map surveyors definition of an established reference point, or “benchmark.” All new measurements are then referenced to that known point, (or benchmark), as having greater or lesser values.

Some of the key points to be contrasted/compared when determining what price range under or overvalues a speculative investment: Magnitude of the possible and probable impact of the science and the exclusive invention; proprietary product--patent or trade secret protection; proven results of the applied invention; development stage or commercial stage of the invention; how long the product lasts; difficulty of duplication; barriers to business or market entry; competitive hurdles; application simplicity; exponential profit probabilities (increasing returns preferable), estimated total market; appeal to consumers; word-of-mouth recommendations by consumers; ease of use; customer benefit and satisfaction, and most of all, will users actually recommend the product to others.

The Legg Mason Health Care Equity Research Group’s May 1998 report titled “The Innovator Pharmaceutical Industry Primer,” quotes a JAMA report that in 1987 treatment of people with chronic diseases accounted for 75% of U.S. health care expenditures. We have seen reports that suggest in 1998 (11 years later) that number was up to about 80%. (Legg Mason is a highly respected brokerage/investment banking firm with headquarters in Baltimore. JAMA is the Journal of the American Medical Association.)

Since U.S. health care annual expenditures now total about $1.5 trillion, that means America’s total annual expenditures for chronic degenerative diseases are now about $1.2 trillion. That is about 12-14% of the current $9-$10 trillion U.S. Gross Domestic Product (GDP). Going beyond the psychic, mental and physical cost in human lives and suffering along with sick time lost, that’s a lot of money going for poor health. There is obviously a need for cheaper, better care and prevention.

However, prevention (prophylaxis), is a tough sale with human nature being what it is. This is one of the reasons we made the Health-Mat ™ so easy to use. To get the benefits, all the successful user has to do is sleep on it with no change in daily routine. Yet, if people would use this simple device, they would not only stand a good chance of avoiding the pain, misery and suffering of most chronic diseases, they might also avoid being a part of the $1.2 trillion (Year 2000) cost. It is rapidly becoming obvious to those paying attention that there is never going to be enough taxpayer money or compassion to take care of the approximately 120,000,000 U.S. citizens that will need chronic disease relief if present chronic disease trends continue.

Many know or can project what happens to the sick when the money runs out and compassion fatigue sets in. Just visit any Medicaid facility or old folks home. Providing healing and lifetime health maintenance for one’s family members by the simple act of having each family member sleep on their own Nyvatex Health-Mat ™ healing energy source may soon become the smart thing to do.

The combined stock market capitalization (number of shares x market price) of all the biotech companies working on a solution to chronic diseases exceeds 200 billion dollars. Many of these companies’ products are chemicals that only suppress or mask symptoms while causing almost intolerable negative side effects. Many of those chronic diseases are already being handled by the patented Nyvatex Health-Mat ™ healing energy technology with no negative side effects.

Yet, Nyvatex’s total market cap in early November 2000 is less than 12 million dollars. (Approximately 43 million shares of Nyvatex common stock outstanding.) If present trends continue, there are 120,000,000 U.S. citizens approaching age 40 and older who are on course to develop some type of chronic affliction. This is a huge market for the Health-Mat ™. It should have broad appeal. It’s based on sound theory. The technology works. The device is inexpensive. It takes no extra time. It is easily used—just sleep on it.

Biotech share prices way outrun product success once stock market participants learn about the potential health impact of frontier technology.

As to the present methods of using chemicals to affect diseases, it is well known that in the attempt to chemically manipulate one thing in highly complex interdependent bio-chemical systems you cannot do “just one thing.” That’s why there are so many negative side effects associated with chemical-based medicine. There are too many cascading changes when that “one thing” is altered. With 3.1 billion DNA base pairs, 100,000 genes, and 100 trillion cells there are 10 to the 30,000^th power possible interactions in the human body. In contrast, calculated total particles in the known universe are only 10 to the 80^th power.

As for human genome (gene-based) solutions, senior proteomic (protein-based, post-genomic) researchers say that it may be decades before they figure out polygenic (many genes interacting) chronic diseases, and maybe late this century before they figure out polygene instructions to make proteins, protein folding, and thereby find root causes of most chronic degenerative diseases. The proteins DNA instructs to be made are the stuff of health and life itself. Damaged DNA makes unhealthy proteins. Unhealthy proteins make chronic diseases.

In contrast, the Nyvatex Health-Mat ™ energy healing device advantageously accepts polygenic instructions to make proteins, preferentially encompasses the natural events of protein manufacture and interaction, and according to theory, goes to the principal root cause of chronic diseases and helps DNA repair itself so the body in effect, cures and “heals itself”.

As the body is in a continuous replacement mode, healed or spontaneously repaired DNA then codes for proper proteins to replace the unhealthy, thereby curing diseased parts. This is also why sleeping on the device every night for the remainder of life is essential, as energy healing and health maintenance is a lifetime necessity. Our energy healing device also boosts cellular communication so that no cell is left in isolation. Cells in isolation aggregate locally and much later, maybe years, become diagnosable as 100’s of variously named chronic diseases.

This is also why there are no negative side effects from use of the Nyvatex Health-Mat ™, only beneficial. This is also why the Nyvatex Health-Mat ™ healing energy technology may be useful in providing a single solution to these chronic diseases that have been given hundreds of names. This is also why we’re working on more patents.

Back to the top

Nyvatex’s Third Technology
(Patent Pending)
We won’t reveal too much about this new energy healing frontier technology at this time. However, those who have seen the patent disclosure documents are wildly enthusiastic about the effect. The invention appears to be patentable to everyone knowledgeable in this area.

This new invention provides a new form of energy that may provide healing, health maintenance, and therefore lives free of chronic degenerative diseases on an active basis. This use is in contrast to the Health-Mat ™ which makes healing and health maintenance energy available on a passive basis. (“Active” means the new device will plug into an electric outlet and be externally powered by electricity. “Passive” in the Health-Mat™ sense means there is no external power; in this case, no magnets, batteries or electric plug.)

Most chronic degenerative diseases (CDD) are currently treated symptomatically, i.e., by using drugs to suppress or mask symptoms. This is why the word “cure” is rarely used when treatments are discussed. The “holy grail” of research (and stock market fortunes) is to find a method that cures (or prevents) the root cause of CDDs. I think this will require a new technological paradigm (Nyvatex’s, for instance) that goes beyond gene and protein therapy which is currently the “hot” area of research (and the stock market).

The three and one-half billion dollar project to decipher the human genome (all genes) is known as The Human Genome Project. The genome is the instruction manual containing the 100,000 or so human genes that govern human development, operation and maintenance. Defects in these genes cause or contribute to almost all human CDDs. Knowing gene geometry is obviously important for gene therapy.

Gene and protein therapy, in the words of senior researchers involved in the Human Genome Project, may take decades (maybe not until late this century) to provide cures. Critics point out that some 97% of the human genome, 3.1 billion of the 3.2 billion codes does not spell out a gene. They are now calling that 3.1 billion codes “junk” DNA. But what if it’s not junk but is essential to the switching on and off for the manufacture of proteins that sustain life and health of the body? At any given moment, 30,000 of the genes in a cell containing 100,000 genes are switching on and off. The switch energizers are not yet understood. Protein folding is not yet understood. There’s a lot left to be understood before “cures” can be found at this molecular level of life itself.

My new invention (patent pending) bypasses this highly complicated level of affecting diseases with its trillions of interactions and probes even deeper into life’s complex behavior right on down to simple organizational laws. These simple organizational laws control self-organizing complexity which control all life. The new invention interacts with these simple organizational imperatives and it may become possible that all chronic degenerative diseases (CDD) may be simply truly cured, as well as prevented. Current U.S. CDD cost: about 1.2 Trillion dollars annually.

Just as with the Harmony Blanket ™, use of this active healing energy invention will not require anything to be injected, ingested, inserted, incised or inhaled into the human body (or pets) to accomplish this. There will be only beneficial side effects, and no negative side effects. It truly meets the test “first do no harm”, as does the Health-Mat ™. (Details are in Nyvatex’s book.)

This invention came from pure thought and observation, without government, corporate or any other institutional support. Arriving at the invention cost about one millionth the $3.5 billion Human Genome Project. Wall Street has already raised many billions of dollars for many new companies to explore gene and protein research. If and when gene and protein based therapy methods work, they will still be very expensive, with yet-to-be-determined immediate and long-term negative side effects. (Some gene therapy experiments have already been suspended due to unexplained deaths.)

My new invention can be profitably produced for a popular retail price affordable for every home, schoolroom, office, etc., just like the Health-Mat ™. Also like the Nyvatex Health-Mat ™, it has beneficial side effects, and no negative side effects.

I would imagine that everyone who hears about this product will want the benefits. Even after the new invention is available to consumers, there will still be a need for sleeping every night on the

Health-Mat ™ to provide the essential energy described in our 230 page book. So even if only the future second generation active energy healing device interests you, you may as well start now with the readily available passive energy healing device which provides the first generation source and form of essential healing energy.

NEITHER NYVATEX OR ITS EMPLOYEES GIVES MEDICAL ADVICE. IF YOU HAVE AN ILLNESS, CONSULT THE DOCTOR OF YOUR CHOICE. ALL INFORMATION FROM NYVATEX IS FOR EDUCATIONAL PURPOSES ONLY.

Back to the top

Nyvatex’s  Bio-Technology Side 
Forward-Looking Statement 
(Safe Harbor Provision)

This report includes “forward-looking statements” within the meaning of the United States federal securities laws that involve a number of risks and uncertainties. The information reflects numerous assumptions as to technology performance, industry performance, general business and economic conditions, regulatory and legal requirements, taxes, and other matters, many of which are beyond the control of Nyvatex or its employees. Similarly, this information assumes certain business decisions that are subject to change. There can be no assurance that the results predicted here will be realized. Actual results may vary from those represented and those variations may be material.

Benchmarking Nyvatex’s 
Common Stock Share Price 
(Oil Exploration)

It is almost impossible to benchmark Nyvatex’s oil finding possibilities. Any selected prospect drillsite may be the “big one.” To be sure, only the drill bit can truly evaluate what the future holds. We believe our oil-finding system technology to be extremely useful, but there are many imponderables in the drilling hunt for big oil. As a wonderful old gray-haired wildcatter with boom and bust experience once told me as I was learning the business, “10,000 things can happen to you when you’re drilling for oil, and only one of them is good.”

There were many other apt sayings: “Almost nothing you do can help a poor oil well, and most everything you do can’t hurt a really good one.” “Never get in a hurry when attempting to produce oil from the earth, you can always come back and screw things up later.” “When hunting for elephants you may find mice, but if you hunt solely for mice you probably won’t find an elephant.” “Try to always go where good luck can happen.” “Try not to waste your time, only fish where there are fish.” “Going catching beats going fishing.” “The meek may inherit the earth, but certainly not its minerals.”

We evaluate our oil and gas prospects using our proprietary oil-finding technology, and hope that we can successfully apply the above truisms.

Nyvatex Oil-Side 
Forward-Looking Statement 
(Safe Harbor Provision):

NYVATEX’s production and drilling plans described in this report constitute “forward-looking statements” within the meaning of the United States federal securities laws that involve risks and uncertainties. The actual results of these plans may vary substantially from expectations as a result of a variety of factors. By way of example and not limitation or prediction:

1. Production may vary from the discussed well(s) when put on daily production and may be higher or significantly lower than initial drilling and testing results due to engineering or geological considerations. (2) There may be delays in putting the well(s) on production leading to delays in revenues. (3) Step-out wells planned for drilling may not materialize, may be delayed, or produce limited oil and/or gas. The failure of any of these factors could cause actual results to differ materially from the forward-looking statements outlined above. Readers are advised to carefully review and consider these disclosures made by NYVATEX, so that interested parties are aware of the risks and factors that may affect NYVATEX’s business, its exclusive, unique, high-technology oil-finding system (AESOP), and investment in or sale of its securities.

This is not an offer to buy or sell securities of the corporation. Securities of the corporation are speculative and carry a high degree of risk.

Back to the top